Chimerix Inc

Ownership Transactions Reported by 17 Insiders

Symbol
CMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2505 Meridian Parkway, Suite 100, Durham, NC

Insiders trading volume in the past year

Chimerix Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cantex Pharmaceuticals, Inc. 10%+ Owner $3.34M Sep 14, 2021
Michael T. Andriole PRESIDENT AND CEO, Director $2.75M -$44K -1.57% Apr 21, 2025
Michael Alrutz Svp And General Counsel $965K -$7.23K -0.74% Apr 21, 2025
Michelle LaSpaluto Chief Financial Officer $780K -$14.4K -1.81% Apr 21, 2025
Fred A. Middleton Director $695K Apr 21, 2025
Allen S. Melemed Chief Medical Officer $688K -$13.8K -1.97% Apr 21, 2025
David Jakeman Vp Of Finance And Accounting $675K -$12.8K -1.86% Apr 21, 2025
Thomas J. Riga COO and CCO $47.6K Apr 21, 2025
Victoria Vakiener Director $0 Apr 21, 2025
Pratik S. Multani Director $0 Apr 21, 2025
Michael A. Sherman Chief Executive Officer, Director $0 Apr 21, 2025
Martha J. Demski Director $0 Apr 21, 2025
Marc D. Kozin Director $0 Apr 21, 2025
Lisa Lynn Decker Director $0 Apr 21, 2025
Robert J. Meyer Director $0 Apr 21, 2025
Catherine Gilliss Director Jun 9, 2023
Patrick Machado Director Jun 9, 2023

Recent Insider Transactions by Companies or Individuals for Chimerix Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.